Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-Induced Neutropenia in Breast Cancer Patients - Drugs.com MedNews
Links shared publicly online about this topic.
- 250total visits
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-Induced Neutropenia in Breast Cancer Patients - Drugs.com MedNews
CG-10639 (formerly Neugranin) Phase II III data demonstrated non-inferiority to pegfilgrastim Dosing study of XM22 supported future Phase III trial of 6mg dose
View full resource at drugs.com
Tags: Cancer, Neutropenia, Neutropenia Medication, Breast Cancer, Drug, Women's Health
Most Recently Shared on June 1, 2011 at 8:02 pm By:
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-... http://bit.ly/lQE2OV #drug
Advertisement
